Evolent Health (EVH) Competitors

Herc (NYSE:HRI) and Evolent Health (NYSE:EVH) are both business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings.

Which has more volatility and risk, HRI or EVH?

Herc has a beta of 1.86, indicating that its share price is 86% more volatile than the S&P 500. Comparatively, Evolent Health has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500.

Do analysts prefer HRI or EVH?

Herc presently has a consensus price target of $144.60, suggesting a potential upside of 11.57%. Evolent Health has a consensus price target of $17.93, suggesting a potential upside of 87.24%. Given Evolent Health's stronger consensus rating and higher possible upside, analysts clearly believe Evolent Health is more favorable than Herc.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Herc	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60
Evolent Health	0 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	1 Strong Buy rating(s)	3.00

Does the media favor HRI or EVH?

In the previous week, Evolent Health had 10 more articles in the media than Herc. MarketBeat recorded 15 mentions for Evolent Health and 5 mentions for Herc. Herc's average media sentiment score of 1.32 beat Evolent Health's score of 0.33 indicating that Herc is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Herc	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Evolent Health	3 Very Positive mention(s)	1 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has preferable earnings and valuation, HRI or EVH?

Herc has higher revenue and earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than Herc, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Herc	$3.54B	1.22	$211M	$0.86	150.70
Evolent Health	$2.55B	0.44	-$61.62M	-$1.61	-5.95

Do institutionals & insiders hold more shares of HRI or EVH?

93.1% of Herc shares are held by institutional investors. 1.3% of Herc shares are held by company insiders. Comparatively, 1.4% of Evolent Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Is HRI or EVH more profitable?

Herc has a net margin of 0.61% compared to Evolent Health's net margin of -5.94%. Herc's return on equity of 20.77% beat Evolent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Herc	0.61%	20.77%	3.38%
Evolent Health	-5.94%	1.83%	0.70%

Summary

Herc beats Evolent Health on 11 of the 17 factors compared between the two stocks.